Literature DB >> 22872453

Endometrial carcinoma: MR staging and causes of error.

P V Foti1, R Farina, M Coronella, C Ruggeri, S Palmucci, A Montana, P Milone, G Zarbo, R Caltabiano, S Lanzafame, G Politi, G C Ettorre.   

Abstract

PURPOSE: This study was undertaken to prospectively determine the diagnostic capabilities of magnetic resonance (MR) imaging in detecting myometrial and cervical invasion and lymph node involvement in endometrial carcinoma and to identify the causes of errors in staging endometrial carcinoma.
MATERIALS AND METHODS: Twenty consecutive patients with a histological diagnosis of endometrial carcinoma underwent preoperative MR imaging. MR findings were compared with surgical staging, considered as the standard of reference.
RESULTS: In assessing myometrial invasion, MR imaging showed 70% accuracy, 80% sensitivity, 40% specificity, 80% positive predictive value (PPV), and 40% negative predictive value (NPV). In detecting cervical invasion, MR imaging had 95% accuracy, 100% sensitivity, 94.4% specificity, 66.7% PPV, and 100% NPV. In evaluating lymph node involvement, MR imaging showed 100% accuracy, sensitivity, specificity, PPV and NPV. Errors in evaluating myometrial invasion were caused by polypoid tumour, adenomyosis and leiomyomas, whereas those in evaluating cervical invasion were caused by dilatation and curettage.
CONCLUSIONS: MR imaging is a reliable technique for preoperative evaluation of endometrial carcinoma. Its main limitation is differentiating between stage IA and IB carcinomas, which is not highly important for surgical planning. Cooperation between the gynaecologist and radiologist is mandatory to avoid staging errors.

Entities:  

Mesh:

Year:  2012        PMID: 22872453     DOI: 10.1007/s11547-012-0861-3

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  14 in total

1.  Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging--initial experience.

Authors:  Gigin Lin; Koon-Kwan Ng; Chee-Jen Chang; Jiun-Jie Wang; Kung-Chu Ho; Tzu-Chen Yen; Tzu-I Wu; Chun-Chieh Wang; Yu-Ruei Chen; Yu-Ting Huang; Shu-Hang Ng; Shih-Ming Jung; Ting-Chang Chang; Chyong-Huey Lai
Journal:  Radiology       Date:  2009-03       Impact factor: 11.105

2.  Myometrial invasion in endometrial cancer: diagnostic performance of diffusion-weighted MR imaging at 1.5-T.

Authors:  Gilda Rechichi; Stefania Galimberti; Mauro Signorelli; Patrizia Perego; Maria Grazia Valsecchi; Sandro Sironi
Journal:  Eur Radiol       Date:  2009-09-02       Impact factor: 5.315

3.  MR imaging of pelvic lymph nodes in primary pelvic carcinoma with ultrasmall superparamagnetic iron oxide (Combidex): preliminary observations.

Authors:  M G Harisinghani; S Saini; G J Slater; M D Schnall; M D Rifkin
Journal:  J Magn Reson Imaging       Date:  1997 Jan-Feb       Impact factor: 4.813

4.  Five classes of extended hysterectomy for women with cervical cancer.

Authors:  M S Piver; F Rutledge; J P Smith
Journal:  Obstet Gynecol       Date:  1974-08       Impact factor: 7.661

5.  Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer.

Authors:  Andrea G Rockall; Syed A Sohaib; Mukesh G Harisinghani; Syed A Babar; Naveena Singh; Arjun R Jeyarajah; David H Oram; Ian J Jacobs; John H Shepherd; Rodney H Reznek
Journal:  J Clin Oncol       Date:  2005-04-20       Impact factor: 44.544

6.  Role of magnetic resonance imaging and cause of pitfalls in detecting myometrial invasion and cervical involvement in endometrial cancer.

Authors:  A Sanjuán; G Escaramís; J R Ayuso; S Martínez Román; A Torné; J Ordi; J A Lejárcegui; J Pahisa
Journal:  Arch Gynecol Obstet       Date:  2008-03-27       Impact factor: 2.344

7.  Myometrial invasion by endometrial carcinoma: assessment by MR imaging.

Authors:  S Sironi; G Taccagni; P Garancini; C Belloni; A DelMaschio
Journal:  AJR Am J Roentgenol       Date:  1992-03       Impact factor: 3.959

8.  Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.

Authors:  Mukesh G Harisinghani; Jelle Barentsz; Peter F Hahn; Willem M Deserno; Shahin Tabatabaei; Christine Hulsbergen van de Kaa; Jean de la Rosette; Ralph Weissleder
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

9.  Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning.

Authors:  Riccardo Manfredi; Paoletta Mirk; Giulia Maresca; Pasquale A Margariti; Antonia Testa; Gian Franco Zannoni; Deborah Giordano; Giovanni Scambia; Pasquale Marano
Journal:  Radiology       Date:  2004-03-18       Impact factor: 11.105

Review 10.  Staging of carcinoma of the uterine cervix and endometrium.

Authors:  Takashi Koyama; Ken Tamai; Kaori Togashi
Journal:  Eur Radiol       Date:  2007-01-12       Impact factor: 7.034

View more
  4 in total

1.  Diagnostic Accuracy of Clinical Biomarkers for Preoperative Prediction of Lymph Node Metastasis in Endometrial Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Casper Reijnen; Joanna IntHout; Leon F A G Massuger; Fleur Strobbe; Heidi V N Küsters-Vandevelde; Ingfrid S Haldorsen; Marc P L M Snijders; Johanna M A Pijnenborg
Journal:  Oncologist       Date:  2019-06-11

2.  An MRI radiomics nomogram improves the accuracy in identifying eligible candidates for fertility-preserving treatment in endometrioid adenocarcinoma.

Authors:  Bi-Cong Yan; Feng-Hua Ma; Ying Li; Yan-Feng Fan; Zhi-Long Huang; Xiao-Liang Ma; Xue-Ting Wen; Jin-Wei Qiang
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

3.  Imaging in endometrial carcinoma.

Authors:  Silvana C Faria; Tara Sagebiel; Aparna Balachandran; Catherine Devine; Chandana Lal; Priya R Bhosale
Journal:  Indian J Radiol Imaging       Date:  2015 Apr-Jun

4.  Diagnostic Accuracy of MRI for Detecting Cervical Invasion in Patients with Endometrial Carcinoma: A Meta-Analysis.

Authors:  Qiu Bi; Guoli Bi; Junna Wang; Jie Zhang; Hongliang Li; Xiarong Gong; Lixiang Ren; Kunhua Wu
Journal:  J Cancer       Date:  2021-01-01       Impact factor: 4.207

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.